The United States of America, which is currently reeling under pressure from the COVID-19 pandemic with over 4,796,348 active cases can look forward to a program of COVID-19 vaccinations in early December, reported CNN.

Moncef Slaoui of Operation Warp Speed, said “Our plan is to be able to ship vaccines to the immunization sites within 24 hours of approval” by the US Food and Drug Administration, as per CNN report.

He added, “So I expect maybe on Day Two of the approval, on the 11th or the 12th of December.”

FDA vaccine advisors reportedly will meet December 8 to 10 to discuss approving vaccines which Pfizer and Moderna say are at least 95 percent effective.

On Saturday the United States reported over 100,000 new cases for the 19th day in a row.

Also Read: WHO envoy warns of third wave of COVID-19 if Europe doesn’t strengthen necessary infrastructure

The beginning of vaccination in the country will be a crucial turning point as over 255,000 people have died from the coronavirus pandemic that originated from the wet markets of China.

Slaoui, a part of the Operation Warp Speed further stated that 20 million people across the United States can be vaccinated in December alone, adding 30 million more could be vaccinated next month onward.

With a dash of caution Slaoui added, “I really hope and look forward to seeing that the level of negative perception of the vaccine decreases and people’s acceptance increases. That is going to be critical to help us.”

The Moroccan-born Belgian-American researcher added that vaccine trials had shown that the new vaccine was 95% effective. He added that while the trials had only ensured short-term safety, decades of scientific research had revealed that nearly all adverse effects of a vaccine occurred within 40 days of its being administered.

Also Read: ‘Third wave of COVID-19 in full swing, situation grave’: South Korean Health Minister

Slaoui further stated that the Pfizer and Moderna vaccines had no serious side effects with in the first 60 days.

While officials are yet to demarcate the groups in population that would receive the vaccine first, healthcare workers are expected to receive priority, followed by elderly vulnerable groups.